• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[二次数据的验证。优势与局限]

[Validation of secondary data. Strengths and limitations].

作者信息

Hoffmann F, Andersohn F, Giersiepen K, Scharnetzky E, Garbe E

机构信息

Universität Bremen, Bremen, BRD.

出版信息

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1118-26. doi: 10.1007/s00103-008-0646-y.

DOI:10.1007/s00103-008-0646-y
PMID:18985405
Abstract

Medical records databases (such as the General Practice Research Database-GPRD) and administrative databases (such as German Statutory Health Insurance (SHI) claims data) are useful sources for pharmacoepidemiology and health services research. However, these data are not primarily collected for research purposes. Validation studies are needed to examine their completeness and accuracy depending on the corresponding research question. This article reviews strategies for checks of internal consistency within the data from one SHI as well as between data from several SHIs and possibilities of internal data validation. Descriptive analyses of consistency can help to determine the integrity of data. The aim of internal validation is to separate uncertain from true cases based on information from secondary data alone or to reproduce known associations within the database. In addition external validation of secondary data is desirable using original prescriptions, medical records, hospital discharge letters and/or patient or physician interviews as a gold standard. A considerable number of external validation studies of diagnostic coding have been conducted within the GPRD. In contrast, such validation studies of German SHI claims data are mostly lacking and are urgently needed in the near future.

摘要

医疗记录数据库(如全科医疗研究数据库-GPRD)和行政数据库(如德国法定医疗保险(SHI)理赔数据)是药物流行病学和卫生服务研究的有用数据源。然而,这些数据并非主要为研究目的而收集。需要进行验证研究,以根据相应的研究问题检查其完整性和准确性。本文回顾了检查来自一个SHI的数据内部一致性以及几个SHI数据之间的一致性的策略,以及内部数据验证的可能性。一致性的描述性分析有助于确定数据的完整性。内部验证的目的是仅根据二次数据中的信息将不确定病例与真实病例区分开来,或在数据库中重现已知的关联。此外,使用原始处方、医疗记录、医院出院信和/或患者或医生访谈作为金标准对二次数据进行外部验证是可取的。在GPRD内已经进行了大量关于诊断编码的外部验证研究。相比之下,德国SHI理赔数据的此类验证研究大多缺乏,在不久的将来迫切需要。

相似文献

1
[Validation of secondary data. Strengths and limitations].[二次数据的验证。优势与局限]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1118-26. doi: 10.1007/s00103-008-0646-y.
2
[Health services research based on routine data generated by the SHI].基于法定健康保险产生的常规数据的卫生服务研究
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1093-4. doi: 10.1007/s00103-008-0643-1.
3
[Health services research based on routine data generated by the SHI. Potential uses of health insurance fund data in health services research].[基于法定健康保险产生的常规数据的卫生服务研究。健康保险基金数据在卫生服务研究中的潜在用途]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1095-105. doi: 10.1007/s00103-008-0644-0.
4
[Pharmacoepidemiological research with large health databases].[利用大型健康数据库进行的药物流行病学研究]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1135-44. doi: 10.1007/s00103-008-0648-9.
5
[Work based on data of the Gmünder Ersatzkasse. An exemplary overview].[基于京德保险库数据的工作。示例概述]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1106-17. doi: 10.1007/s00103-008-0645-z.
6
[Pharmacoepidemiology. Analysis of drug prescription data].[药物流行病学。药物处方数据分析]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1145-54. doi: 10.1007/s00103-008-0649-8.
7
[Using claims data for small area analysis and controlling of hospital care].[利用索赔数据进行医院护理的小区域分析与控制]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1183-92. doi: 10.1007/s00103-008-0653-z.
8
[Measurement of medical outcome quality using administative data in Germany].[利用德国行政数据测量医疗结果质量]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1173-82. doi: 10.1007/s00103-008-0652-0.
9
[Secondary data analysis in the field of epidemiology of health care. Potential and limitations].[医疗保健流行病学领域的二次数据分析。潜力与局限]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1193-201. doi: 10.1007/s00103-008-0654-y.
10
[Data protection and methodological aspects in compiling a routine database from statutory health insurance data for research purposes].[出于研究目的从法定健康保险数据编制常规数据库时的数据保护和方法学方面]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1127-34. doi: 10.1007/s00103-008-0647-x.

引用本文的文献

1
Epidemiology and treatment patterns of essential tremor: a retrospective cohort analysis in Germany.特发性震颤的流行病学及治疗模式:德国的一项回顾性队列分析
Front Neurol. 2025 Jul 2;16:1580919. doi: 10.3389/fneur.2025.1580919. eCollection 2025.
2
Frequency, combinations and clinical relevance of outpatient low back pain diagnoses: analysis of claims data in a population-based cohort study.门诊腰痛诊断的频率、组合及临床相关性:基于人群队列研究的索赔数据分析
BMC Musculoskelet Disord. 2025 Apr 3;26(1):330. doi: 10.1186/s12891-025-08514-1.
3
Internal validation of self-reported case numbers in hospital quality reports: preparing secondary data for health services research.
医院质量报告中自我报告病例数的内部验证:为卫生服务研究准备二手数据。
BMC Med Res Methodol. 2024 Dec 31;24(1):325. doi: 10.1186/s12874-024-02429-6.
4
Prevalence of HIV in people with potential HIV-indicator conditions in Germany: an analysis of data from statutory health insurances.德国潜在HIV指示性疾病患者中的HIV流行率:法定医疗保险数据分析
EClinicalMedicine. 2024 Jun 24;73:102694. doi: 10.1016/j.eclinm.2024.102694. eCollection 2024 Jul.
5
Prognostic impact of disease-related complications in asymptomatic mitral regurgitation: a health insurance claims analysis.无症状性二尖瓣反流中疾病相关并发症的预后影响:一项医疗保险理赔分析。
Clin Res Cardiol. 2024 Aug 28. doi: 10.1007/s00392-024-02532-0.
6
Routine Data Analysis of HIV Pre-Exposure Prophylaxis Use and Rates of Sexually Transmitted Infections Since Coverage of HIV Pre-Exposure Prophylaxis by the Statutory Health Insurance in Germany.德国法定健康保险覆盖 HIV 暴露前预防措施后,HIV 暴露前预防措施使用和性传播感染率的常规数据分析。
Arch Sex Behav. 2024 Oct;53(9):3663-3672. doi: 10.1007/s10508-024-02922-5. Epub 2024 Aug 6.
7
Value of Electronic Health Records Measured Using Financial and Clinical Outcomes: Quantitative Study.使用财务和临床结果衡量电子健康记录的价值:定量研究
JMIR Med Inform. 2024 Jan 24;12:e52524. doi: 10.2196/52524.
8
Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study.过敏性呼吸道疾病患者的生活质量和医疗保健费用:一项横断面研究。
Eur J Health Econ. 2024 Jun;25(4):579-600. doi: 10.1007/s10198-023-01598-3. Epub 2023 Jul 7.
9
Sex Disparities in Long-Term Mortality after Paclitaxel Exposure in Patients with Peripheral Artery Disease: A Nationwide Claims-Based Cohort Study.外周动脉疾病患者接受紫杉醇治疗后长期死亡率的性别差异:一项基于全国索赔数据的队列研究
J Clin Med. 2021 Jul 2;10(13):2978. doi: 10.3390/jcm10132978.
10
Pregnancy rates and perinatal outcomes in women with systemic lupus erythematosus: data from the Korean national health claims database.系统性红斑狼疮女性的妊娠率和围产期结局:来自韩国国家健康保险索赔数据库的数据。
Clin Rheumatol. 2021 Jun;40(6):2243-2250. doi: 10.1007/s10067-020-05496-4. Epub 2020 Nov 12.